Actively Recruiting

Phase Not Applicable
All Genders
ID05553223

Can Micro-doses of Physical Activity Offset the Negative Cardiovascular Consequences of Being Sedentary in Patients With COPD?

Led by University of British Columbia · Updated on 2025-04-04

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing difficult and causes patients to spend more time sitting or lying down. This study aims to find out how sitting still for 3 hours affects blood vessel health in people with COPD. It also examines if breaking up sitting time with short 5-minute walks each hour can help maintain healthier blood vessels and reduce cardiovascular risks. The study uses a randomized crossover design where participants act as their own controls. Participants will take part in two different sessions separated by at least six days. In one session, they will sit or recline for 3 hours without moving, and in the other, they will sit for 3 hours but take short 5-minute walks each hour. Before each session, their diet will be standardized, and they will avoid moderate to vigorous physical activity, alcohol, and caffeine, arriving fasting for tests. Physical activity levels will be tracked with an accelerometer during the days leading up to and including the test days. Throughout each session, blood samples and vascular health measurements will be taken at the start and after 1, 2, and 3 hours of sitting. Blood pressure will also be monitored continuously for 24 hours after the first session. Researchers will analyze changes in blood vessel function, blood flow patterns, arterial stiffness, and blood pressure to understand the effects of prolonged sitting versus interrupted sitting with physical activity. The total involvement includes multiple visits over several weeks, with careful monitoring and follow-up assessments.

CONDITIONS

Brief Title

Micro-doses of Physical Activity for COPD

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Non-smoking for more than 6 months
  • Stable moderate-to-severe COPD with airflow obstruction confirmed by lung function tests
  • Forced Expired Volume in 1 second between 30% and 80% predicted
  • No exacerbations or flare-ups for more than 6 weeks
  • Able to participate in physical activity and walking sessions
Not Eligible

You will not qualify if you...

  • Currently performing structured exercise training or pulmonary rehabilitation
  • History of deep vein thrombosis
  • Taking anticoagulant medication
  • Advanced cardiac or cerebrovascular disease such as heart failure, previous stroke, or myocardial infarction
  • Diagnosis of diabetes
  • Musculoskeletal problems limiting physical activity
  • Unable to obtain vascular ultrasound measurements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Baseline Assessment

Duration - 1 day

Participants undergo a pulmonary function test to confirm airflow obstruction severity and are given an accelerometer to measure habitual physical activity and sedentary time.

1 visit (in-person)

Randomized Experimental Visits

Duration - 2 days separated by at least 6 days

Participants complete two randomized visits: one involving 3 hours of prolonged sitting and the other involving 3 hours of sitting interspersed with 5-minute walking bouts every hour.

2 visits (in-person)

24-hour Ambulatory Monitoring

Duration - 24 hours after each visit

Participants wear a 24-hour ambulatory blood pressure monitor following each experimental visit to assess blood pressure changes.

2 ambulatory monitoring periods

Trial Site Locations

Total: 1 location

1

University of British Columbia

Kelowna, British Columbia, Canada, V1V2L2

Actively Recruiting

Loading map...

Research Team

N

Neil Eves, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Multifactorial Risk Stratification in Acute and Chronic Card...

Cardiovascular Diseases

Actively Recruiting

2 locations

Beneficial Effects of Perfect Heartio Drink in Improving Car...

Cardiovascular Diseases

Actively Recruiting

1 location

"Smart Family Doctor" Assisted Comprehensive Management of S...

Post Coronary Artery Bypass Grafting

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here